Compare Cigna Corp (CI) vs Lululemon Athletica Inc (LULU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Lululemon Athletica Inc — how do they compare? Cigna Corp trades at $274.2 (market cap $73.56B), while Lululemon Athletica Inc trades at $123.18 (market cap $14.26B). The key difference: Cigna Corp is far larger — about 5.2× Lululemon Athletica Inc's market cap, and Cigna Corp pays a 2.24% dividend while Lululemon Athletica Inc pays none. Which is the better fit depends on your goals.
| CI | LULU | |
|---|---|---|
Market Cap | $73.56B | $14.26B |
Sector | Health | Consumer Cyclical |
52-Week High | $311.00 | $215.88 |
52-Week Low | $244.41 | $105.43 |
Enterprise Value | $98.27B | $14.89B |
Dividend Yield | 2.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $278.40, down 1.45% on the day, with a bearish technical signal but strong fundamentals including a P/E of 11.51 and ROE of 15.49%. Recent Q2 2026 earnings beat expectations at $7.78 per share, and the company raised its full-year EPS guidance. The stock is supported by consistent dividend payments and robust cash flow from operations of $9.60 billion in 2025.
The outlook is positive with a consensus price target of $338.90, implying 22% upside. Key opportunities include steady earnings growth and capital returns, while risks involve healthcare cost pressures and competitive dynamics. Analyst sentiment is strongly bullish with 73.68% buy ratings, though technical indicators suggest near-term caution.
Lululemon (LULU) trades at $127.80, down 0.61% today but near the consensus price target of $129.29. The stock shows strong fundamentals with a P/E of 10.17, net income margin of 13.03%, and consistent earnings beats in recent quarters. Technical indicators are mixed with a bullish moving average signal but overbought RSI levels. Recent news highlights international growth and operational improvements, though the broader apparel sector faces headwinds.
The outlook is cautiously optimistic given solid profitability and valuation support, but risks include sector-wide demand pressures and high investor expectations. Upside potential exists if international expansion continues to offset domestic softness, while failure to maintain margins or growth could trigger downside. Analyst consensus leans neutral with 52% hold ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Lululemon Athletica Inc
Lululemon Athletica Inc. designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. Lululemon offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. The company also sells fitness accessories, such as bags, yoga mats, and equipment. Lululemon sells its products through more than 600 company-owned stores in 18 countries, e-commerce, outlets, and wholesale accounts. The company was founded in 1998 and is based in Vancouver, Canada.
Read more on LULU →
